Dr Jan Hedner Explores Benefit of Sulthiame, New Avenue in SDB Treatment
May 21st 2024Jan Hedner, MD, PhD, finds sulthiame improves sleep quality and reduces daytime sleepiness in patients with sleep-disordered breathing (SDB), offering a potential alternative to continuous positive airway pressure (CPAP) machines. This highlights the growing field of non-CPAP treatments, with personalized medicine being a key focus for future research.
Read More
Exploring Critical Advances in ARDS, Asthma, Lung Cancer, Health Equity at ATS 2024
May 20th 2024During a session at the American Thoracic Society (ATS) 2024 International Conference, experts presented the most impactful data from the last year on acute respiratory distress syndrome (ARDS), childhood asthma, health equity, and lung cancer.
Read More
Dr Adam Benjafield Addresses Improved Outcomes With ASV in Opioid Users With CSA
May 20th 2024In research presented at the American Thoracic Society 2024 International Conference, Benjafield and colleagues explored the treatment of sleep-disordered breathing with adaptive sero-ventilation (ASV) in opioid users with central sleep apnea (CSA).
Read More
Dr Paul Frohna Discusses Promising Results of Novel Hedgehog Inhibitor for IPF
May 20th 2024Promising results from a phase 2 trial of ENV-101, a novel hedgehog inhibitor, showed improvement in lung function and reduction of fibrosis in patients with idiopathic pulmonary fibrosis, said Paul Frohna, MD, PhD, PharmD.
Read More
As AI Utilization Advances in Health Care, Experts at ATS 2024 Share Insights
May 20th 2024Fatima Rodriguez, MD, MPH, from Stanford University, and Matthew DeCamp, MD, PhD, from the University of Colorado, joined Michael Howell, MD, MPH, of Google, on the stage at ATS 2024 to discuss artificial intelligence (AI) in health care.
Read More
Dr Surya Bhatt Discusses the Role of Dupilumab in Type 2 Inflammation, Exacerbations in COPD
June 2nd 2023Surya Bhatt, MD, associate professor of medicine at University of Alabama at Birmingham, talks about a new trial in which dupilumab was used in patients with chronic obstructive pulmonary disease (COPD) with frequent exacerbations and type 2 inflammation.
Read More
Dr Chitra Lal: Low Threshold Screening Needed for OSA
May 25th 2023Chitra Lal, MD, D-ABSM, FCCP, FAASM, FACP, ATSF, professor of medicine at Medical University of South Carolina, says that the screening threshold for obstructive sleep apnea (OSA) should be low because 70% to 75% of patients with mild cognitive impairment have sleep apnea.
Read More
Dr Debra Boyer: Despite Setbacks, Some Pediatric Pulmonary Treatments Have Improved
May 25th 2023Debra Boyer, MD, pediatric pulmonologist at Nationwide Children’s Hospital and co-chair of the American Thoracic Society International Conference Committee says that even though there are strides to be made in pediatric pulmonology, treatments for children with diseases, such as cystic fibrosis, have improved.
Read More
ATS 2023 Abstracts Highlight Risk Factors for COPD Outside of Smoking
May 24th 2023A range of posters presented at the 2023 American Thoracic Society (ATS) International Conference highlighted a plethora of risk factors for pulmonary conditions in adulthood outside of tobacco smoking history.
Read More
Comorbidities Among Patients With COPD Impact Outcomes, Require Further Research
May 24th 2023A symposium at the 2023 American Thoracic Society International Conference highlighted common comorbidities that warrant consideration in patients who present with chronic obstructive pulmonary disease (COPD).
Read More
Dr Franco Laghi: Home-Based Physical Activity Served Patients During COVID-19 Pandemic
May 23rd 2023Franco Laghi, MD, a professor and pulmonologist affiliated with Loyola University Medical Center as well as the Edward Hines, Jr. Veterans Affairs Hospital in Maywood, Illinois, discussed the use of home-based exercise rehabilitation programs for veterans with long COVID-19, and patient reluctance to come to a medical facility during the pandemic.
Read More
Dr Chitra Lal: OSA Might Be a Modifiable Risk Factor for Alzheimer Disease
May 23rd 2023Chitra Lal, MD, D-ABSM, FCCP, FAASM, FACP, ATSF, professor of medicine at Medical University of South Carolina, talks about how there might be a link between obstructive sleep apnea (OSA) and Alzheimer disease (AD), and that treating sleep apnea early and aggressively may help prevent AD development.
Read More
Dr Gerard Criner: Long-term Evaluation New for Patients With Emphysema
May 23rd 2023Gerard Criner, MD, FACP, FACCP, professor and founding chair, Thoracic Medicine and Surgery, at the Lewis Katz School of Medicine at Temple University, discusses a new trial that investigated how long treatment would last for patients with emphysema, and if any complications arose.
Read More
Measuring and Addressing the Environmental Factors That Impact Social Determinants of Health
May 22nd 2023Quantifying social determinants of health and addressing the factors that allow disparities to persist will require standardized measurements and targeted interventions, said a panel of experts at the 2023 American Thoracic Society International Conference.
Read More
Pediatric Patients With Respiratory Diseases Need More Resources, Says Dr Debra Boyer
May 22nd 2023Debra Boyer, MD, pediatric pulmonologist at Nationwide Children’s Hospital and co-chair of the American Thoracic Society (ATS) International Conference Committee, highlights the need for more specialized care and research for children with respiratory diseases, who don't have access to the same therapies and testing as adults.
Read More
Dr Rupal Shah: The COVID-19 Pandemic Accelerated Remote Spirometry Opportunity
May 21st 2023Rupal Shah, MD, associate professor at the University of California San Francisco, talks about how the onset of the COVID-19 pandemic created an opportunity for patients who have undergone a lung transplant to undergo spirometry testing at home instead of at the the hospital.
Read More
Phase 3 Study Finds Dupilumab Reduces COPD Exacerbations in Patients With Type 2 Inflammation
May 21st 2023In the phase 3 BOREAS study of patients with chronic obstructive pulmonary disease (COPD) and type 2 inflammation, patients treated with dupilumab experienced fewer COPD exacerbations, improved lung function, and improved quality of life compared with patients given a placebo.
Read More
ATS International Conference to Highlight Key Research and Themes in Respiratory Medicine
May 16th 2023This year’s American Thoracic Society (ATS) International Conference will spotlight not only the latest research in respiratory medicine, but also timely themes such as minority health equity, the effects of climate on health, and reducing gun violence through advocacy.
Read More
Dr Horace DeLisser Says ATS Will Consist of State-of-the-Art Information, Reconnection
May 16th 2023Horace DeLisser, MD, associate dean for diversity and inclusion in undergraduate medical education at the Perelman School of Medicine at the University of Pennsylvania and associate professor of medicine in the pulmonary, allergy, and critical care division, looks forward to the American Thoracic Society (ATS) international conference to reconnect with friends and colleagues and stay up to date on clinical knowledge and controversial topics.
Read More
ATS 2021 Abstracts Identify Factors Influencing Hospitalization Risks for COPD
May 27th 2021Abstracts from the ATS 2021 International Conference addressed patient decision-making frameworks for seeking care for chronic obstructive pulmonary disease (COPD) and tactics used to assist hospitals in implementing readmission reduction plans.
Read More
What Factors Can Help Improve the Effectiveness of Pulmonary Rehabilitation in COPD?
May 25th 2021Abstracts from the ATS 2021 International Conference provided some insight into tactics that could improve the effectiveness of pulmonary rehabilitation programs in patients with chronic obstructive pulmonary disease (COPD).
Read More
Characteristics of COPD Vary Among Different Demographics and Smoking Statuses
May 21st 2021Posters presented at the ATS 2021 International Conference noted some ways clinical characteristics associated with patients with chronic obstructive pulmonary disease (COPD) differ based on different demographics and smoking status.
Read More
After an ICU Stay, Dual-Eligible Beneficiaries Have More Disability
May 19th 2021It is already known that dual-eligible older adults are at an increased risk for death in the year following a stay in the intensive care unit (ICU), but it previously wasn't known whether dual-eligible status is linked with functional decline after an ICU stay.
Read More
Posters Examine Impact of Chronic Cough on Quality of Life, Diagnosis Delays
May 19th 2021Patients with refractory or unexplained chronic cough are concerned about how they appear to others, and it takes them many years to get diagnosed, according to posters presented at the American Thoracic Society 2021 International Conference.
Read More